Here is a copy of my letter......Anyone can edit it to fit them. I am e-mailing it to the above address
Dear Dr. Maas, Diabetes Research and Development at Sanofi and
Mr Christopher Vienbacher CEO:
I am a vigilant mother of a 10 year old boy with diabetes since age 2.
The struggles he faces to get through the day are heart breaking.
The tools (i.e. pumps, cgms, insulin...) we have thus far to manage his diabetes are just band aides.
I believe, as many others do in the diabetes community, that HIP is our answer.
Human Islet Peptide is part of the Reg3a gene that makes new islets
from pancreatic progenitor cells. This is known in the type 1
diabetes community. Sanofi-Aventis is being unfair to millions of people with diabetes,
whom they have committed to be an innovative leader in the field.
For the company to give up its islet neogenisis program with a human peptide, before it starts is unjust.
Please move this project forward. Sanofi-Aventis giving up on this
before human trials will set back diabetes for decades.